| Community Kid's Kare,inc. | |
|
532 Fine Way, Alma, AR 72921-7761 | |
| (479) 719-4893 | |
| Not Available |
| Full Name | Community Kid's Kare,inc. |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 532 Fine Way, Alma, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780800748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR824 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Community Kid's Kare,inc. 532 Fine Way, Alma, AR 72921-7761 Ph: (479) 719-4893 | Community Kid's Kare,inc. 532 Fine Way, Alma, AR 72921-7761 Ph: (479) 719-4893 |
News Archive
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.
The day may be getting a little closer when robots will perform surgery on patients in dangerous situations or in remote locations, such as on the battlefield or in space, with minimal human guidance.
Wyeth Pharmaceuticals, a division of Wyeth, has announced that the European Commission has approved TORISEL (temsirolimus) for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL is the only approved cancer therapy that specifically inhibits the mTOR (mammalian target of rapamycin) kinase, an important regulator of cell proliferation, cell growth and cell survival.
The beginning of the MoreGrasp project was marked by the idea of a groundbreaking further development of grasp neuroprosthetics activated by thought control.
› Verified 9 days ago
Molly Elizabeth Chilton, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 344 Fayetteville Ave, Alma, AR 72921 Phone: 479-632-4600 | |
Jennifer June Perez, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 344 Fayetteville Ave, Alma, AR 72921 Phone: 479-632-4600 | |
Morgan Paige Collier, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 344 Fayetteville Ave, Alma, AR 72921 Phone: 479-632-4600 | |
Miracle Alyse Warren, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 344 Fayetteville Ave, Alma, AR 72921 Phone: 479-632-4600 | |
Glena Kay Mackey, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 532 Fine Way, Alma, AR 72921 Phone: 479-719-4893 |